SHELTON, CT / ACCESS Newswire / July 21, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the ...

The rapid emergence and re-emergence of viral pathogens—exemplified by outbreaks of influenza, Ebola, Zika, and, most recently, SARS-CoV-2—underscore the ...

Many known viruses pose a continuing threat to public health, and we are constantly dealing with the possibility that new viruses could emerge .. | Microbiology ...

U.S. Antiviral Drugs Market to Surpass USD 27.07 Billion by 2032, Fueled by Chronic Infection Treatment Demand and Strong R&D Ecosystem.Austin, July 17, 2025 (GLOBE NEWSWIRE) -- Antiviral Drugs Market ...

Severe fever with thrombocytopenia syndrome (SFTS) was reported in Asia, with a fatality rate that can reach as high as 50%.

A new medical study out of Johns Hopkins Children's Center could potentially be a game changer for those suffering certain mental disorders.

Alzheimer's disease, affecting millions, is projected to surge by 2050. Research suggests a potential link between herpes simplex virus type 1 (HSV-1) and Alzheimer's. A recent study reveals that ...

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and should even be effective against new strains ...

Centre for Health Protection says Covid activity has declined in city, while doctors warn move may place burden on public ...

Our lead drug candidate is NV-387, a broad-spectrum antiviral drug that we plan to develop as a treatment of RSV, COVID, Long COVID, Influenza, and other respiratory viral infections, as well as ...